Crizer D, Rice J, Smeltz M, Lavrich K, Ravindra K, Wambaugh J
Toxics. 2024; 12(9).
PMID: 39330600
PMC: 11435625.
DOI: 10.3390/toxics12090672.
Korzekwa K, Nagar S
Drug Metab Dispos. 2023; 51(4):532-542.
PMID: 36623886
PMC: 10043942.
DOI: 10.1124/dmd.122.001060.
Kiesel B, Deppas J, Guo J, Parise R, Clump D, Bakkenist C
Cancer Chemother Pharmacol. 2022; 89(6):795-807.
PMID: 35507041
PMC: 10082586.
DOI: 10.1007/s00280-022-04436-0.
Kiesel B, Guo J, Parise R, Venkataramanan R, Clump D, Bakkenist C
Cancer Chemother Pharmacol. 2022; 89(2):231-242.
PMID: 35066692
PMC: 8829872.
DOI: 10.1007/s00280-021-04388-x.
Venuto C, Talal A
Clin Pharmacol Drug Dev. 2017; 6(2):169-175.
PMID: 28263459
PMC: 5859954.
DOI: 10.1002/cpdd.311.
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model.
Kuepfer L, Niederalt C, Wendl T, Schlender J, Willmann S, Lippert J
CPT Pharmacometrics Syst Pharmacol. 2016; 5(10):516-531.
PMID: 27653238
PMC: 5080648.
DOI: 10.1002/psp4.12134.
Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.
Yang K, Guo C, Woodhead J, St Claire 3rd R, Watkins P, Siler S
J Pharm Sci. 2016; 105(2):443-459.
PMID: 26869411
PMC: 4894499.
DOI: 10.1016/j.xphs.2015.11.008.
Representative Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations.
Schwen L, Schenk A, Kreutz C, Timmer J, Bartolome Rodriguez M, Kuepfer L
PLoS One. 2015; 10(7):e0133653.
PMID: 26222615
PMC: 4519332.
DOI: 10.1371/journal.pone.0133653.
Spatio-temporal simulation of first pass drug perfusion in the liver.
Schwen L, Krauss M, Niederalt C, Gremse F, Kiessling F, Schenk A
PLoS Comput Biol. 2014; 10(3):e1003499.
PMID: 24625393
PMC: 3952820.
DOI: 10.1371/journal.pcbi.1003499.
Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies.
De Buck S, Jakab A, Boehm M, Bootle D, Juric D, Quadt C
Br J Clin Pharmacol. 2014; 78(3):543-55.
PMID: 24617631
PMC: 4243905.
DOI: 10.1111/bcp.12378.
Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.
Mould D, Upton R
CPT Pharmacometrics Syst Pharmacol. 2013; 2:e38.
PMID: 23887688
PMC: 3636497.
DOI: 10.1038/psp.2013.14.
An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model.
Jin X, Pybus B, Marcsisin R, Logan T, Luong T, Sousa J
Eur J Drug Metab Pharmacokinet. 2013; 39(2):139-46.
PMID: 23797843
DOI: 10.1007/s13318-013-0139-8.
Effect of chronic hypoxic hypoxia on oxidation and glucuronidation of carvedilol in rats.
Yamaura S, Fukao M, Ishida K, Taguchi M, Hashimoto Y
Eur J Drug Metab Pharmacokinet. 2013; 39(1):53-9.
PMID: 23739952
DOI: 10.1007/s13318-013-0140-2.
Pharmacokinetics of tacrolimus during pregnancy.
Zheng S, Easterling T, Umans J, Miodovnik M, Calamia J, Thummel K
Ther Drug Monit. 2012; 34(6):660-70.
PMID: 23007747
PMC: 3498613.
DOI: 10.1097/FTD.0b013e3182708edf.
Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat.
Umehara K, Camenisch G
Pharm Res. 2011; 29(2):603-17.
PMID: 22011931
DOI: 10.1007/s11095-011-0607-2.
Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study.
Boyce M, Baisley K, Warrington S
Br J Clin Pharmacol. 2011; 73(3):411-21.
PMID: 21883386
PMC: 3370345.
DOI: 10.1111/j.1365-2125.2011.04093.x.
An integrated drug-likeness study for bicyclic privileged structures: from physicochemical properties to in vitro ADME properties.
Han C, Zhang J, Zheng M, Xiao Y, Li Y, Liu G
Mol Divers. 2011; 15(4):857-76.
PMID: 21538133
DOI: 10.1007/s11030-011-9317-2.
The relative importance of CYP26A1 in hepatic clearance of all-trans retinoic acid.
Thatcher J, Zelter A, Isoherranen N
Biochem Pharmacol. 2010; 80(6):903-12.
PMID: 20513361
PMC: 2906711.
DOI: 10.1016/j.bcp.2010.05.023.
Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.
Dudhani R, Turnidge J, Coulthard K, Milne R, Rayner C, Li J
Antimicrob Agents Chemother. 2009; 54(3):1117-24.
PMID: 20028824
PMC: 2826009.
DOI: 10.1128/AAC.01114-09.
Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
Verbeeck R, Musuamba F
Eur J Clin Pharmacol. 2009; 65(8):757-73.
PMID: 19543887
DOI: 10.1007/s00228-009-0678-8.
